Search research articles
Contact Us
Filters
Showing results (71-80 of 157) with videos related to
Page
of 16
Sort By:
Journal of Clinical Trials
|
September 19, 2024
Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022)
Rebecca A Snyder, Shauna L Hillman, Veronique Marcotte, et al.
Journal of the National Cancer Institute
|
August 23, 2015
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
Ming-Wen An, Xinxin Dong, Jeffrey Meyers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 22, 2010
Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival
Yan Li, Michael J Krowka, Yingwei Qi, et al.
Clinical Trials (London, England)
|
July 24, 2018
Application of multi-state models in cancer clinical trials
Jennifer G Le-Rademacher, Ryan A Peterson, Terry M Therneau, et al.
Journal of the National Cancer Institute
|
September 26, 2024
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies
Sheila A Prindiville, Sumithra J Mandrekar, Neal J Meropol, et al.
Cancers
|
November 7, 2020
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials
Jennifer G Le-Rademacher, Shauna Hillman, Elizabeth Storrick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2012
Effect of cigarette smoking on quality of life in small cell lung cancer patients
Jun Chen, Yingwei Qi, Jason A Wampfler, et al.
Blood Advances
|
June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
The Oncologist
|
December 25, 2019
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
Kaushal Parikh, Sumithra J Mandrekar, Katie Allen-Ziegler, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 17, 2020
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients
Jennifer Le-Rademacher, Camden Lopez, Eric Wolfe, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 157) with videos related to
Sort By:
Page
of 16
Journal of Clinical Trials
|
September 19, 2024
Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022)
Rebecca A Snyder, Shauna L Hillman, Veronique Marcotte, et al.
Journal of the National Cancer Institute
|
August 23, 2015
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
Ming-Wen An, Xinxin Dong, Jeffrey Meyers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 22, 2010
Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival
Yan Li, Michael J Krowka, Yingwei Qi, et al.
Clinical Trials (London, England)
|
July 24, 2018
Application of multi-state models in cancer clinical trials
Jennifer G Le-Rademacher, Ryan A Peterson, Terry M Therneau, et al.
Journal of the National Cancer Institute
|
September 26, 2024
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies
Sheila A Prindiville, Sumithra J Mandrekar, Neal J Meropol, et al.
Cancers
|
November 7, 2020
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials
Jennifer G Le-Rademacher, Shauna Hillman, Elizabeth Storrick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2012
Effect of cigarette smoking on quality of life in small cell lung cancer patients
Jun Chen, Yingwei Qi, Jason A Wampfler, et al.
Blood Advances
|
June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
The Oncologist
|
December 25, 2019
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
Kaushal Parikh, Sumithra J Mandrekar, Katie Allen-Ziegler, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 17, 2020
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients
Jennifer Le-Rademacher, Camden Lopez, Eric Wolfe, et al.
Page
of 16